Common sense approaches to urinary biomarker study design.
about
Biomarkers for childhood-onset systemic lupus erythematosusMulticentric validation of proteomic biomarkers in urine specific for diabetic nephropathyProteomic identification of early biomarkers of acute kidney injury after cardiac surgery in children.Urinary netrin-1 is an early predictive biomarker of acute kidney injury after cardiac surgery.Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.Uromodulin exclusion list improves urinary exosomal protein identification.Implementation of proteomic biomarkers: making it work.Biomarkers and updates on pediatrics lupus nephritis.Application of systems biology principles to protein biomarker discovery: urinary exosomal proteome in renal transplantation.A roadmap for successful applications of clinical proteomics.Urinary exosomes and proteomics.Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications.Clinical application of urinary proteomics/peptidomics.Network views for personalized medicine.Recommendations for biomarker identification and qualification in clinical proteomics.Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis.Challenges and opportunities for discovery of disease biomarkers using urine proteomics.Urinary exosomal expression of activator of G protein signaling 3 in polycystic kidney disease.How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MSExtracellular Vesicles in Bladder Cancer: Biomarkers and Beyond
P2860
Q27007470-3BAF8060-5386-49AB-9383-4B41D21E855FQ28748796-1126F9A8-A432-4BA6-911A-C880DD19114EQ30985164-C6CCA757-3B0B-4938-B70B-AF614AC10E13Q33684008-510A7A56-D09F-45C2-B5DE-F436CC298264Q34330358-6F570C7F-D4CC-41C0-9ADB-DEB08CEF2EB5Q35565450-E3E65FB5-FC5E-4531-94B5-AD8E8884B8B5Q36297774-F44C3E8D-170D-40B5-AFC9-15AB3B48009EQ37167062-9653A36C-0BBF-4DA4-AFF2-AF7BCF5B2B5AQ37257354-26BAD461-7FC2-4323-875C-EEBA46B2A248Q37869461-07C30E0F-3AB2-4AE7-B857-435309FB502DQ37872261-BF1C3A42-A355-4434-8647-CD19DB087AF4Q37876853-ECD3D904-76E5-4623-95D5-97102451649EQ37945790-C7A7C8F2-C1B6-4A71-83BF-A1D386245878Q42694013-07D79D97-B92A-43C5-B886-DEE38B38AB34Q45200767-0F9A9E46-AFA8-4349-A52C-8EE4AECD694BQ46474917-AC95257F-EC4D-46F8-9898-210F7AF08453Q51794241-FE40A6BC-CFB1-4E53-82A7-01F76F28FAB2Q55265318-882B9970-734B-49CC-9F62-FC88D9B2C810Q57711927-DE943F89-2E37-4C75-9342-549CC67F12A6Q58722406-7557A346-5C82-4247-B83B-2C388F162547
P2860
Common sense approaches to urinary biomarker study design.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Common sense approaches to urinary biomarker study design.
@en
Common sense approaches to urinary biomarker study design.
@nl
type
label
Common sense approaches to urinary biomarker study design.
@en
Common sense approaches to urinary biomarker study design.
@nl
prefLabel
Common sense approaches to urinary biomarker study design.
@en
Common sense approaches to urinary biomarker study design.
@nl
P2860
P356
P1476
Common sense approaches to urinary biomarker study design.
@en
P2093
Mark A Knepper
P2860
P304
P356
10.1681/ASN.2009030321
P577
2009-05-21T00:00:00Z